摘要
炎症在多种血管床的动脉粥样硬化过程中发挥着关键作用,从内皮功能紊乱开始和包含血小板整个的发展阶段。炎症在动脉粥样硬化的起始和发展中的重大贡献已被记录了许多年,但其对与其他心血管疾病发展的贡献仍不清楚。炎症过程构成主动脉疾病(包括主动脉瓣狭窄和主动脉瘤)致病性的一个基本部分。因此,这两个实体均与高发病率和死亡率有关。因此,检测和调查并能够反映疾病进程的且以测量的炎症指数的需求是非常强烈的。然而,这种主动脉疾病的生物标记物,能够对高危病人的早期诊断提供一个重要的存活预后值,但这样的标志物仍然很少。因此,这种生物标记作用的阐明,将有助于对负责主动脉疾病发生的分子和/或细胞水平机制的了解。这一方法能够为早期诊断提供一个病理生理基础。
关键词: 主动脉瘤,主动脉疾病,主动脉夹层,主动脉瓣狭窄,生物标志物。
Current Medicinal Chemistry
Title:Novel Inflammatory Indices in Aortic Disease
Volume: 22 Issue: 23
Author(s): Manolis Vavuranakis, Maria Kariori, Dimitrios Vrachatis, Gerasimos Siasos, Konstantinos Kalogeras, Evelina Bei, Carmen Moldovan, , Maria Lavda, Konstantinos Aznaouridis, Evangelos Oikonomou and Dimitris Tousoulis
Affiliation:
关键词: 主动脉瘤,主动脉疾病,主动脉夹层,主动脉瓣狭窄,生物标志物。
摘要: Inflammation plays a critical role in the atherosclerotic process in various vascular beds, starting from endothelial dysfunction and counting all stages of plaque development. The significant contribution of inflammation in the initiation and progression of atherosclerosis has been documented over many years but its contribution to the development of other cardiovascular disease remains unclear. Inflammatory process constitutes a basic part of pathogenic cascade of aortic diseases including those of aortic valve stenosis and aortic aneurysms. Thus, both of these entities are related with high rates of morbidity and mortality. Therefore, the need to detect and investigate indices representative of inflammation that will be easily measured and may reflect the process of these diseases, is mandatory. However, such biomarkers for aortic diseases that could have a significant prognostic value on survival via the early identification of high risk patients, in general, remain few. Therefore, the illumination of role of such biomarkers, will facilitate the understanding of the mechanisms in molecular and/or cellular level that are responsible for the creation of aortic disease. Such an approach may provide a pathophysiological basis for early diagnosis.
Export Options
About this article
Cite this article as:
Manolis Vavuranakis , Maria Kariori , Dimitrios Vrachatis , Gerasimos Siasos , Konstantinos Kalogeras , Evelina Bei , Carmen Moldovan , , Maria Lavda , Konstantinos Aznaouridis , Evangelos Oikonomou and Dimitris Tousoulis , Novel Inflammatory Indices in Aortic Disease, Current Medicinal Chemistry 2015; 22 (23) . https://dx.doi.org/10.2174/0929867322666150630141035
DOI https://dx.doi.org/10.2174/0929867322666150630141035 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antihypertensive Treatments in Patients Affected by Aortic Valve Stenosis
Current Pharmaceutical Design Prostaglandin J2 Family and the Cardiovascular System
Current Vascular Pharmacology <sup>177</sup>Lu-Labeled Agents for Neuroendocrine Tumor Therapy and Bone Pain Palliation in Uruguay
Current Radiopharmaceuticals Role of Inflammatory Cells and Toll-Like Receptors in Atherosclerosis
Current Vascular Pharmacology The Role of the Methoxyphenol Apocynin, a Vascular NADPH Oxidase Inhibitor, as a Chemopreventative Agent in the Potential Treatment of Cardiovascular Diseases
Current Vascular Pharmacology Allograft-Induced Proliferation of Vascular Smooth Muscle Cells: Potential Targets for Treating Transplant Vasculopathy
Current Vascular Pharmacology Protective Effects of Diuretics Against the Development of Cardiovascular Disease in Patients with Chronic Kidney Disease: A Systematic Review
Cardiovascular & Hematological Agents in Medicinal Chemistry Endothelial Dysfunction in Hyperglycemia as a Trigger of Atherosclerosis
Current Diabetes Reviews Instructions from the Vascular System - Directing Neural Stem Cell Fate in Health and Disease
Current Medicinal Chemistry Towards the Development of Tumor Necrosis Factor (TNF) Sensitizers:Making TNF Work Against Cancer
Current Pharmaceutical Design Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
Current Pharmaceutical Design Emerging Therapeutic Approaches Multi-Targeting Receptor Tyrosine Kinases and G Protein-Coupled Receptors in Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Brain Protection and Cognitive Function: Cocoa Flavonoids as Nutraceuticals
Current Pharmaceutical Design Genetic Basis, Nutritional Challenges and Adaptive Responses in the Prenatal Origin of Obesity and Type-2 Diabetes
Current Diabetes Reviews Is Age of 80 Years a Threshold for Carotid Revascularization?
Current Cardiology Reviews The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
Current Pharmaceutical Design Inhibitors of Serine Proteinases from Blood Coagulation Cascade - View on Current Developments
Mini-Reviews in Medicinal Chemistry Clinical Features of Scleroderma-Like Disorders: A Challenge for the Rheumatologist
Current Rheumatology Reviews Edaravone (3-Methyl-1-Phenyl-2-Pyrazolin-5-one), A Novel Free Radical Scavenger, for Treatment of Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Mechanisms of Neurodegeration in Type 2 Diabetes and the Neuroprotective Potential of Dipeptidyl Peptidase 4 Inhibitors
Current Medicinal Chemistry